Hammink Roel, Weiden Jorieke, Voerman Dion, Popelier Carlijn, Eggermont Loek J, Schluck Marjolein, Figdor Carl G, Verdoes Martijn
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
ACS Appl Mater Interfaces. 2021 Apr 14;13(14):16007-16018. doi: 10.1021/acsami.0c21994. Epub 2021 Apr 2.
A variety of bioactive materials developed to expand T cells for adoptive transfer into cancer patients are currently evaluated in the clinic. In most cases, T cell activating biomolecules are attached to rigid surfaces or matrices and form a static interface between materials and the signaling receptors on the T cells. We hypothesized that a T cell activating polymer brush interface might better mimic the cell surface of a natural antigen-presenting cell, facilitating receptor movement and concomitant advantageous mechanical forces to provide enhanced T cell activating capacities. Here, as a proof of concept, we synthesized semiflexible polyisocyanopeptide (PIC) polymer-based immunobrushes equipped with T cell activating agonistic anti-CD3 (αCD3) and αCD28 antibodies placed on magnetic microbeads. We demonstrated enhanced efficiency of expansion of activated primary human T cells even at very low numbers of stimulating antibodies compared to rigid beads. Importantly, the immunobrush architecture appeared crucial for this improved T cell activating capacity. Immunobrushes outperform current benchmarks by producing higher numbers of T cells exhibiting a combination of beneficial phenotypic characteristics, such as reduced exhaustion marker expression, high cytokine production, and robust expression of cytotoxic hallmarks. This study indicates that semiflexible immunobrushes have great potential in making T cell-based immunotherapies more effective.
目前,临床上正在评估多种为将T细胞扩增后过继转移至癌症患者体内而研发的生物活性材料。在大多数情况下,T细胞激活生物分子附着于刚性表面或基质上,并在材料与T细胞上的信号受体之间形成静态界面。我们推测,T细胞激活聚合物刷界面可能更能模拟天然抗原呈递细胞的细胞表面,促进受体移动以及随之产生的有利机械力,从而提供更强的T细胞激活能力。在此,作为概念验证,我们合成了基于半柔性聚异氰肽(PIC)聚合物的免疫刷,其配备了置于磁性微珠上的T细胞激活激动性抗CD3(αCD3)和αCD28抗体。与刚性微珠相比,我们证明了即使在刺激抗体数量非常少的情况下,激活的原代人T细胞的扩增效率也有所提高。重要的是,免疫刷结构对于这种改善的T细胞激活能力似乎至关重要。免疫刷通过产生更多数量具有有益表型特征组合的T细胞,如降低耗竭标志物表达、高细胞因子产生以及细胞毒性特征的强劲表达,从而优于当前的基准。这项研究表明,半柔性免疫刷在提高基于T细胞的免疫疗法的有效性方面具有巨大潜力。